125 related articles for article (PubMed ID: 3974937)
1. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
[TBL] [Abstract][Full Text] [Related]
2. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
[TBL] [Abstract][Full Text] [Related]
3. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
Böhles H; Michalk D; von Wendt-Göknur E
Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
[TBL] [Abstract][Full Text] [Related]
4. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
[TBL] [Abstract][Full Text] [Related]
5. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
Glöggler A; Bulla M; Fürst P
Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. L-carnitine in haemodialysed patients. Changes in lipid pattern.
Casciani CU; Caruso U; Cravotto E; D'Iddio S; Corsi M; Pola P; Savi L; Grilli M
Arzneimittelforschung; 1982; 32(3):293-7. PubMed ID: 7200788
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the effect of d,l-carnitine on lipid metabolism of patients after prolonged dialysis].
Król E; Rutkowski B; Manitius J; Manitius A; Sałek J; Wróblewska M; Lysiak-Szydłowska W
Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):614-6. PubMed ID: 1669126
[TBL] [Abstract][Full Text] [Related]
9. The effect of L-carnitine on lipid metabolism in patients on chronic haemodialysis.
Yderstraede KB; Pedersen FB; Dragsholt C; Trostmann A; Laier E; Larsen HF
Nephrol Dial Transplant; 1987; 1(4):238-41. PubMed ID: 3110681
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients.
Duranay M; Akay H; Yilmaz FM; Senes M; Tekeli N; Yücel D
Nephrol Dial Transplant; 2006 Nov; 21(11):3211-4. PubMed ID: 16861734
[TBL] [Abstract][Full Text] [Related]
11. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.
Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M
Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175
[TBL] [Abstract][Full Text] [Related]
12. [Results of a multicenter study on the effect on serum triglycerides and cholesterol administration of carnitine in chronic uremia patients undergoing periodic hemodialysis treatment].
Toigo G; Situlin R; Dardi F; Bazzato G; Vasile A; Tesio F; Ciman M; Guarnieri GF
G Clin Med; 1982; 63(11-12):841-9. PubMed ID: 7182204
[No Abstract] [Full Text] [Related]
13. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
[TBL] [Abstract][Full Text] [Related]
14. Effect of carnitine on serum HDL-cholesterol: report of two cases.
Rossi CS; Siliprandi N
Johns Hopkins Med J; 1982 Feb; 150(2):51-4. PubMed ID: 7057619
[TBL] [Abstract][Full Text] [Related]
15. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
[TBL] [Abstract][Full Text] [Related]
16. Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients.
Naini AE; Sadeghi M; Mortazavi M; Moghadasi M; Harandi AA
Saudi J Kidney Dis Transpl; 2012 May; 23(3):484-8. PubMed ID: 22569432
[TBL] [Abstract][Full Text] [Related]
17. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
19. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
20. Effect of l-carnitine on lipid pattern in debilitated patients treated with Intralipid.
Pola P; Tondi P; Flore R; Serricchio M; Dal Lago A; Amanti C; Consorti F; Benedetti M; Midiri H
Int J Clin Pharmacol Res; 1983; 3(3):179-84. PubMed ID: 6592157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
